CGTX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2023-11-02 compared with 2023-08-08 · 2 added, 5 removed, 27 unchanged (21% of the section changed)
2 unchanged sentences
Exhibit Description
−Removed: Second Amended and Restated Bylaws of Cognition Therapeutics, Inc.
−Removed: Employment Agreement, dated April 17, 2023, between Cognition Therapeutics, Inc.
−Removed: and John Doyle
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
Cognition Therapeutics, Inc.
−Removed: August 8, 2023
+Added: November 2, 2023
/s/ Lisa Ricciardi
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 8, 2023
+Added: November 2, 2023
/s/ John Doyle
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.